Jia-Horng Kao Selected Research

alpha-Fetoproteins (alpha-Fetoprotein)

10/2023	Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months.
3/2022	Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
1/2020	Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
12/2019	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
1/2019	Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
11/2011	Alpha-fetoprotein in chronic hepatitis C.
11/2006	Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma.
7/2005	Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.
6/2003	Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jia-Horng Kao Research Topics

Disease

167	Infections 05/2024 - 01/2002
113	Chronic Hepatitis B 03/2024 - 01/2002
102	Fibrosis (Cirrhosis) 04/2024 - 09/2002
82	Chronic Hepatitis C 04/2024 - 10/2002
73	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2002
69	Hepatitis B 02/2024 - 01/2002
39	Liver Diseases (Liver Disease) 04/2024 - 09/2002
35	Hepatitis 02/2024 - 01/2003
26	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 07/2005
21	Neoplasms (Cancer) 04/2024 - 04/2002
21	Hepatitis C 01/2024 - 11/2002
21	Disease Progression 01/2023 - 09/2006
20	Virus Diseases (Viral Diseases) 04/2023 - 01/2007
14	Chronic Hepatitis (Chronic Active Hepatitis) 11/2012 - 09/2002
9	Insulin Resistance 10/2014 - 08/2005
8	Fatty Liver 01/2024 - 01/2005
8	Coinfection 05/2022 - 01/2002
7	Viremia 10/2023 - 01/2003
6	Inflammation (Inflammations) 01/2024 - 01/2005
6	Non-alcoholic Fatty Liver Disease 04/2023 - 08/2009
5	Obesity 01/2024 - 05/2010
5	Chronic Renal Insufficiency 10/2022 - 06/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 08/2009
4	Hemorrhage 08/2023 - 12/2016
4	Hyperbilirubinemia 04/2023 - 04/2007
4	Persistent Infection 07/2010 - 01/2003
3	Liver Neoplasms (Liver Cancer) 04/2024 - 01/2022
3	Diabetes Mellitus 04/2024 - 05/2010
3	COVID-19 12/2023 - 06/2023
3	Carcinogenesis 01/2023 - 12/2018
3	Body Weight (Weight, Body) 10/2015 - 11/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010 - 01/2005
2	Hyperlipidemias (Hyperlipidemia) 04/2024 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2024

Drug/Important Bio-Agent (IBA)

99	Antiviral Agents (Antivirals)IBA 05/2024 - 01/2003
75	Hepatitis B e AntigensIBA 04/2024 - 01/2002
75	InterferonsIBA 01/2022 - 11/2002
69	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2024 - 10/2002
60	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 01/2002
48	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 11/2002
39	Alanine Transaminase (SGPT)IBA 04/2024 - 01/2003
23	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2006
21	entecavir FDA Link 02/2024 - 01/2006
18	SofosbuvirIBA 01/2024 - 01/2016
16	Lamivudine (Epivir)FDA Link 02/2015 - 02/2002
15	RNA (Ribonucleic Acid)IBA 08/2023 - 06/2003
13	AntigensIBA 01/2023 - 01/2002
12	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2023 - 11/2006
12	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 01/2006
11	daclatasvirIBA 01/2021 - 11/2014
9	glecaprevir and pibrentasvirIBA 04/2024 - 10/2018
9	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023 - 06/2003
8	Tenofovir (Viread)FDA Link 02/2024 - 01/2010
8	CytokinesIBA 07/2023 - 12/2011
8	asunaprevirIBA 01/2021 - 11/2014
8	Interferon-alpha (Interferon Alfa)IBA 07/2016 - 12/2002
7	nasIBA 03/2024 - 01/2014
7	LipidsIBA 01/2024 - 06/2008
7	AdiponectinIBA 04/2015 - 08/2005
6	velpatasvirIBA 01/2024 - 12/2018
6	CholesterolIBA 11/2023 - 07/2007
6	Triglycerides (Triacylglycerol)IBA 11/2023 - 06/2008
6	VaccinesIBA 06/2023 - 09/2011
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2011
6	sofosbuvir drug combination ledipasvirIBA 08/2022 - 07/2016
5	TransferasesIBA 11/2023 - 09/2009
5	BilirubinIBA 06/2023 - 03/2018
5	NucleotidesIBA 06/2021 - 10/2002
5	ledipasvirIBA 12/2018 - 06/2016
5	Surface Antigens (Surface Antigen)IBA 03/2018 - 06/2012
5	Transaminases (Aminotransferases)IBA 08/2017 - 11/2006
5	Codon (Codons)IBA 07/2014 - 01/2002
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 07/2016
4	Ritonavir (Norvir)FDA Link 12/2018 - 10/2016
4	Telbivudine FDA Link 01/2017 - 01/2014
4	peginterferon alfa-2b (Pegintron)FDA Link 10/2014 - 01/2006
3	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 03/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 03/2010
3	tenofovir alafenamideIBA 02/2024 - 01/2022
3	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2017
3	gadolinium ethoxybenzyl DTPA FDA Link 12/2023 - 01/2012
3	acarboxyprothrombin (PIVKA)IBA 01/2023 - 03/2022
3	Sorafenib (BAY 43-9006)FDA Link 11/2017 - 06/2015
3	Viral DNAIBA 08/2017 - 11/2006
3	Genetic Markers (Genetic Marker)IBA 06/2017 - 05/2015
3	NucleosidesIBA 06/2016 - 01/2013
3	AdipokinesIBA 04/2015 - 02/2008
3	adefovir dipivoxil (Hepsera)FDA Link 02/2015 - 01/2006
3	Complement System Proteins (Complement)IBA 09/2014 - 01/2013
3	Amino Acids FDA Link 01/2011 - 09/2002

Therapy/Procedure

150	Therapeutics 04/2024 - 04/2002
12	Liver Transplantation 01/2023 - 01/2008
11	Renal Dialysis (Hemodialysis) 03/2023 - 01/2005
8	Duration of Therapy 10/2023 - 05/2005
7	Aftercare (After-Treatment) 08/2022 - 07/2005
5	Drug Therapy (Chemotherapy) 01/2020 - 01/2008
4	Kidney Transplantation 08/2023 - 07/2010
4	Highly Active Antiretroviral Therapy (HAART) 02/2012 - 02/2007
3	Retreatment 01/2023 - 01/2014
3	Immunotherapy 12/2022 - 01/2017